|
|
Line 15: |
Line 15: |
|
| |
|
| =Text= | | =Text= |
| {{#Wiki_filter:* SHINE Medical Technologies AFFIDAVIT OF RICHARD VANN BYNUM STATE OF WISCONSIN) ss.COUNTY OF DANE I, Richard Vann Bynum, Chief Operating Officer of SHINE Medical Technologies, Inc. (SHINE), do hereby affirm and state: 1. I am authorized to execute this affidavit on behalf of SHINE. I am authorized to review information submitted to or discussed with the Nuclear Regulatory Commission (NRC) and apply for the withholding of information from public disclosure. | | {{#Wiki_filter:* SHINE Medical Technologies AFFIDAVIT OF RICHARD VANN BYNUM STATE OF WISCONSIN |
| The purpose of this affidavit is to provide the information required by 10 CFR 2.390(b) in support of SHINE's request for proprietary treatment of certain confidential commercial information contained in the SHINE Medical Technologies, Inc. Discussion Notes Associated with March 20, 2014 Meeting with NRC. SHINE requests that the confidential information contained in the SHINE Medical Technologies, Inc. Discussion Notes Associated with March 20, 2014 Meeting with NRC be withheld from public disclosure. | | ) ss. |
| | COUNTY OF DANE I, Richard Vann Bynum, Chief Operating Officer of SHINE Medical Technologies, Inc. (SHINE), |
| | do hereby affirm and state: |
| | : 1. I am authorized to execute this affidavit on behalf of SHINE. I am authorized to review information submitted to or discussed with the Nuclear Regulatory Commission (NRC) and apply for the withholding of information from public disclosure. The purpose of this affidavit is to provide the information required by 10 CFR 2.390(b) in support of SHINE's request for proprietary treatment of certain confidential commercial information contained in the SHINE Medical Technologies, Inc. Discussion Notes Associated with March 20, 2014 Meeting with NRC. SHINE requests that the confidential information contained in the SHINE Medical Technologies, Inc. Discussion Notes Associated with March 20, 2014 Meeting with NRC be withheld from public disclosure. |
| : 2. I have knowledge of the criteria used by SHINE in designating information as sensitive, proprietary, or confidential. | | : 2. I have knowledge of the criteria used by SHINE in designating information as sensitive, proprietary, or confidential. |
| : 3. Pursuant to the provisions of paragraph (a)(4) of 10 CFR 2.390, the following is furnished for NRC consideration in determining whether the information sought to be withheld from public disclosure should be withheld.a. The information sought to be withheld from public disclosure contained in the SHINE Medical Technologies, Inc. Discussion Notes Associated with March 20, 2014 Meeting with NRC is owned by SHINE, its affiliates or third parties to whom SHINE has an obligation to maintain its confidentiality. | | : 3. Pursuant to the provisions of paragraph (a)(4) of 10 CFR 2.390, the following is furnished for NRC consideration in determining whether the information sought to be withheld from public disclosure should be withheld. |
| This information is and has been held in confidence by SHINE.b. The information sought to be protected in the SHINE Medical Technologies, Inc. Discussion Notes Associated with March 20, 2014 Meeting with NRC is not available to the public to the best of my knowledge and belief.1 | | : a. The information sought to be withheld from public disclosure contained in the SHINE Medical Technologies, Inc. Discussion Notes Associated with March 20, 2014 Meeting with NRC is owned by SHINE, its affiliates or third parties to whom SHINE has an obligation to maintain its confidentiality. This information is and has been held in confidence by SHINE. |
| : c. The information contained in the SHINE Medical Technologies, Inc.Discussion Notes Associated with March 20, 2014 Meeting with NRC is of the type that is customarily held in confidence by SHINE, and there is a rational basis for doing so. The information that SHINE is requesting to be withheld from public disclosure includes trade secret, commercial information or information that is subject to export controls. | | : b. The information sought to be protected in the SHINE Medical Technologies, Inc. Discussion Notes Associated with March 20, 2014 Meeting with NRC is not available to the public to the best of my knowledge and belief. |
| SHINE limits access to these elements to those individuals with a "need to know," and subject those individuals to maintaining confidentiality. | | 1 |
| : d. The proprietary information sought to be withheld from public disclosure in the SHINE Medical Technologies, Inc. Discussion Notes Associated with March 20, 2014 Meeting with NRC includes, but is not limited to: structural configuration, primary and supporting systems of the medical isotope facility, process and system locations, and process details. This would include information regarding the types, quantities, and locations of materials stored on site as would be referenced in facility configuration drawings. | | : c. The information contained in the SHINE Medical Technologies, Inc. |
| Public disclosure of the information in the SHINE Medical Technologies, Inc.Discussion Notes Associated with March 20, 2014 Meeting with NRC would create substantial harm to SHINE because it would reveal trade secrets owned by SHINE, its affiliates or third parties to whom SHINE has an obligation to maintain its confidentiality. | | Discussion Notes Associated with March 20, 2014 Meeting with NRC is of the type that is customarily held in confidence by SHINE, and there is a rational basis for doing so. The information that SHINE is requesting to be withheld from public disclosure includes trade secret, commercial information or information that is subject to export controls. SHINE limits access to these elements to those individuals with a "need to know," and subject those individuals to maintaining confidentiality. |
| : e. The information contained in the SHINE Medical Technologies, Inc.Discussion Notes Associated with March 20, 2014 Meeting with NRC is transmitted to the NRC in confidence and under the provisions of 10 CFR 2.390; it is to be received in confidence by the NRC. The information is properly marked.I declare under the penalty of perjury that the foregoing is true and correct.Executed on March 17, 2014.Richard VanBynum, Ph.D.COO -SHINE Medical Technologies, Inc.2}} | | : d. The proprietary information sought to be withheld from public disclosure in the SHINE Medical Technologies, Inc. Discussion Notes Associated with March 20, 2014 Meeting with NRC includes, but is not limited to: structural configuration, primary and supporting systems of the medical isotope facility, process and system locations, and process details. This would include information regarding the types, quantities, and locations of materials stored on site as would be referenced in facility configuration drawings. Public disclosure of the information in the SHINE Medical Technologies, Inc. |
| | Discussion Notes Associated with March 20, 2014 Meeting with NRC would create substantial harm to SHINE because it would reveal trade secrets owned by SHINE, its affiliates or third parties to whom SHINE has an obligation to maintain its confidentiality. |
| | : e. The information contained in the SHINE Medical Technologies, Inc. |
| | Discussion Notes Associated with March 20, 2014 Meeting with NRC is transmitted to the NRC in confidence and under the provisions of 10 CFR 2.390; it is to be received in confidence by the NRC. The information is properly marked. |
| | I declare under the penalty of perjury that the foregoing is true and correct. |
| | Executed on March 17, 2014. |
| | Richard VanBynum, Ph.D. |
| | COO - SHINE Medical Technologies, Inc. |
| | 2}} |
Letter Sequence Request |
---|
|
Administration
- Withholding Request Acceptance, Withholding Request Acceptance, Withholding Request Acceptance, Withholding Request Acceptance, Withholding Request Acceptance, Withholding Request Acceptance, Withholding Request Acceptance, Withholding Request Acceptance, Withholding Request Acceptance, Withholding Request Acceptance, Withholding Request Acceptance, Withholding Request Acceptance, Withholding Request Acceptance, Withholding Request Acceptance, Withholding Request Acceptance, Withholding Request Acceptance
|
MONTHYEARML13172A3612013-05-31031 May 2013 Part Two of the Shine Medical Technologies, Inc. Application for Construction Permit Project stage: Request ML13269A3782013-09-25025 September 2013 Shine Medical Technologies, Inc., Submittal of Preliminary Emergency Plan Project stage: Other ML14119A0432014-03-17017 March 2014 Affidavit for Shine Medical Technologies, Inc. Discussion Notes Associated with March 20, 2014 Meeting Project stage: Request ML14121A5342014-05-0808 May 2014 Shine Medical Technologies, Inc., Request for Withholding Information from Public Disclosure Project stage: Withholding Request Acceptance ML14195A1592014-09-19019 September 2014 Shine Medical Technologies, Inc. - Request for Additional Information Regarding Application for Construction Permit Project stage: RAI ML14356A5282014-12-0303 December 2014 Shine Medical Technologies, Inc. Application for Construction Permit Response to Request for Additional Information Project stage: Response to RAI ML15005A4072015-01-0606 January 2015 Shine Medical Technologies, Inc., Request for Additional Information Regarding Application for Construction Permit Project stage: RAI ML15043A3952015-02-0606 February 2015 Shine Medical Technologies, Inc. - Application for Construction Permit - Response to Request for Additional Information Project stage: Response to RAI ML15037A2492015-03-0303 March 2015 Shine Medical Technologies, Inc., - Proposed Review Schedule, Notice of Hearing, Opportunity to Petition for Leave to Intervene, and Order Imposing Procedures Project stage: Other ML15037A1082015-03-0404 March 2015 Federal Register Notice - Notice of Hearing, Opportunity to Petition for Leave to Intervene, and Order Imposing Procedures for Access to Sensitive Unclassified Non-Safeguards Information for Contention Preparation on a Construction Permit f Project stage: Request ML15092A4072015-03-23023 March 2015 Shine Medical Technologies, Inc., Application for Construction Permit, Response to Request for Additional Information 11.1-9 Project stage: Response to RAI ML15055A1162015-03-25025 March 2015 Shine Medical Technologies, Inc., - Request for Additional Information Regarding Application for Construction Permit Project stage: RAI ML15120A2412015-04-10010 April 2015 Shine Medical Technologies, Inc., Application for Construction Permit, Response to Request for Additional Information Project stage: Response to RAI ML15099A6072015-04-15015 April 2015 Shine Medical Technologies, Inc., - Request for Additional Information Regarding Application for Construction Permit(Tac Nos. MF2305, MF2307, and MF2308) Project stage: RAI ML15131A4622015-05-0101 May 2015 Shine Medical Technologies, Inc. Application for Construction Permit, Response to Request for Additional Information Project stage: Response to RAI ML15147A2032015-05-14014 May 2015 Shine Medical Technologies, Inc., Application for Construction Permit, Response to Request for Additional Information Project stage: Response to RAI ML15140A7342015-05-20020 May 2015 Shine Medical Technologies, Inc. Application for Construction Permit, Response to Request for Additional Information 13a2.2-5 Project stage: Response to RAI ML15140A7222015-05-21021 May 2015 Shine Medical Technologies, Inc., Request for Withholding Information from Public Disclosure Project stage: Withholding Request Acceptance ML15140A7232015-05-21021 May 2015 Shine Medical Technologies, Inc. - Request for Withholding Information from Public Disclosure Project stage: Withholding Request Acceptance ML15140A7242015-05-21021 May 2015 Shine Technologies, Inc. - Request for Withholding Information from Public Disclosure Project stage: Withholding Request Acceptance ML15140A7252015-05-21021 May 2015 Shine Technologies, Inc. - Request for Withholding Information from Public Disclosure Project stage: Withholding Request Acceptance ML15140A7262015-05-21021 May 2015 Shine Technologies, Inc. - Request for Withholding Information from Public Disclosure Project stage: Withholding Request Acceptance ML15140A7312015-05-21021 May 2015 Shine Technologies, Inc. - Request for Withholding Information from Public Disclosure Project stage: Withholding Request Acceptance ML15161A3432015-05-21021 May 2015 Shine Medical Technologies, Inc. Preliminary Safety Analysis Report Revisions Resulting from Request for Additional Information Responses Project stage: Request ML15175A2132015-06-16016 June 2015 Shine Medical Technologies V. 0 - Chapter 06 - Engineered Safety Features Project stage: Request ML15175A1312015-06-16016 June 2015 Shine Medical Technologies, Inc. Application for Construction Permit Revision to Sections 13b.3 and 19.4 of the Preliminary Safety Analysis Report Project stage: Request ML15183A2902015-06-19019 June 2015 Shine Medical Technologies, Inc. Application for Construction Permit - Response to Request for Additional Information Project stage: Response to RAI ML15222A2012015-07-23023 July 2015 Shine Medical Technologies, Inc. Application for Construction Permit Response to Request for Additional Information 6b.3-30 Project stage: Response to RAI ML15236A1272015-08-0707 August 2015 Shine Medical Technologies, Inc. Application for Construction Permit Submittal of Atkins-NS-TR-SHN-15-06, Revision 1 Project stage: Request ML15219A3032015-08-27027 August 2015 Shine Medical Technologies Inc., Request for Withholding Information from Public Disclosure Project stage: Withholding Request Acceptance ML15219A2632015-08-27027 August 2015 Shine Medical Technologies Inc., Request for Withholding Information from Public Disclosure Project stage: Withholding Request Acceptance ML15219A3352015-08-27027 August 2015 Shine Medical Technologies Inc., Request for Withholding Information from Public Disclosure Project stage: Withholding Request Acceptance ML15219A1822015-08-27027 August 2015 Shine Medical Technologies Inc., Request for Withholding Information from Public Disclosure Project stage: Withholding Request Acceptance ML15219A3852015-08-27027 August 2015 Shine Medical Technologies Inc., Request for Withholding Information from Public Disclosure Project stage: Withholding Request Acceptance ML15219A1632015-08-27027 August 2015 Shine Medical Technologies Inc., Request for Withholding Information from Public Disclosure Project stage: Withholding Request Acceptance ML15219A4252015-08-27027 August 2015 Shine Medical Technologies Inc. - Request for Withholding Information from Public Disclosure Project stage: Withholding Request Acceptance ML15244A7712015-08-27027 August 2015 Draft Request for Additional Information Shine Medical Technologies, Inc. Preliminary Safety Analysis Report Supporting a Construction Permit Application Project stage: Draft RAI ML15244A5062015-08-27027 August 2015 E-mail from Steven Lynch to Jim Costedio Transmitting Draft Request for Additional Information Supporting Shine PSAR Project stage: Draft RAI ML15247A0672015-09-0202 September 2015 Shine Medical Technologies, Inc. Application for Construction Permit Response to Request for Additional Information Project stage: Response to RAI ML15259A0242015-09-15015 September 2015 Shine Medical Technologies, Inc. - Application for Construction Permit, Revision 1 of Shine Response to Request for Additional Information 6b.3-34 Project stage: Response to RAI ML15259A1642015-09-24024 September 2015 Shine Medical Technologies, Inc., - Request for Additional Information Regarding Application for Construction Permit Project stage: RAI ML15267A2912016-01-0606 January 2016 June 19, 2015 Shine Technologies, Inc., - Request for Withholding Information from Public Disclosure Project stage: Withholding Request Acceptance ML15267A2672016-01-0606 January 2016 July 23, 2015 Shine Technologies, Inc., - Request for Withholding Information from Public Disclosure Project stage: Withholding Request Acceptance 2015-04-15
[Table View] |
|
---|
Category:Legal-Affidavit
MONTHYEARML22271A9672022-09-28028 September 2022 Enclosure 4: Affidavit of James Costedio ML22249A1252022-08-31031 August 2022 Shine Technologies, LLC Final Safety Analysis Report - Application for an Operating License Supplement No. 30, Cover Letter ML22202A4522022-07-21021 July 2022 Enclosure 3: Shine Technologies, LLC - Affidavit of James Costedio ML22188A1972022-07-0707 July 2022 Shine Technologies, LLC, Application for an Operating License Supplement No. 27 - Affidavit of James Costedio ML22188A0582022-07-0707 July 2022 Enclosure 2 - Affidavit of James Costedio ML22164A8182022-06-13013 June 2022 Shine Technologies, LLC: Affidavit of James Costedio ML22161A9782022-06-10010 June 2022 Shine Technologies, LLC - Affidavit of James Costedio ML22032A3432022-02-0101 February 2022 Shine Technologies, LLC, Application for an Operating License Revision 1 of the Shine Response to Request for Additional Information 11-2 - Affidavit of James Costedio ML22028A2252022-01-28028 January 2022 Shine Technologies, LLC, Response to Request for Additional Information on Application for an Operating License - Affidavit ML22027A6682022-01-27027 January 2022 Shine Technologies, LLC, Operating License Application Supplement No. 16 Submittal of a Revision to the Shine Emergency Plan - Affidavit ML22027A3572022-01-27027 January 2022 Shine Technologies, LLC, Application for an Operating License Supplement No. 15 Submittal of the Phased Startup Operations Application Supplement - Affidavit of James Costedio ML22027A6722022-01-27027 January 2022 Shine Technologies, LLC Operating License Application Supplement No. 17 Submittal of a Revision to the Shine Material Control and Accounting Plan - Affidavit ML22034A6132022-01-26026 January 2022 Shine Technologies, LLC, Application for Operating License Supplement 14, Revision to Final Safety Analysis Report ML21326A2102021-11-22022 November 2021 Enclosure 4: Affidavit of James Costedio ML21272A3452021-09-29029 September 2021 Shine Medical Technologies, LLC - Affidavit of James Costedio ML21271A0772021-09-28028 September 2021 Shine Medical Technologies, LLC, Application for an Operating License Revision 1 of Shine Response to Request for Additional Information 3.4-12 - Affidavit of James Costedio ML21243A2702021-08-31031 August 2021 Enclosure 3 - Affidavit of James Costedio ML21183A1292021-07-0202 July 2021 Enclosure 3: Shine Medical Technologies, LLC, Application for an Operating License, Response to Request for Additional Information, Affidavit of James Costedio ML21011A2242020-12-15015 December 2020 Shine Medical Technologies, LLC - Operating License Application Supplement No. 6 and Response to Request for Additional Information ML20357A0892020-12-10010 December 2020 Shine Medical Technologies, LLC Operating License Application Supplement No. 5 and Response to Request for Additional Information ML20255A0272020-08-28028 August 2020 Shine Medical Technologies, LLC Operating License Application Response to Request for Additional Information and Supplement No. 3 ML20188A3012020-06-17017 June 2020 Shine Medical Technologies, LLC - Response to Request for Additional Information on Operating License Application ML20115E5422020-04-24024 April 2020 Shine Medical Technologies, LLC Submittal of Annual Financial Report ML20105A2952020-03-27027 March 2020 Shine Medical Technologies, LLC, Supplement 2 to License Application, Rev.2 to Final Safety Analysis Report ML20069B1612020-02-24024 February 2020 Transmittal of Meeting Slides for the March 4 and 5, 2020 Public Meeting Between Shine Medical Technologies, LLC and the NRC ML19339E7212019-12-0202 December 2019 Transmittal of Meeting Slides for the December 4 and 5, 2019 Public Meeting Between Shine Medical Technologies, LLC and the NRC ML19337A2752019-11-14014 November 2019 Shine Medical Technologies, LLC Supplement 1 to Final Safety Analysis Report ML19211C0442019-07-17017 July 2019 Shine Medical Technologies, LLC Application for an Operating License ML19163A1322019-06-10010 June 2019 Shine Medical Technologies, Inc. Submittal of Annual Financial Report ML19071A0562019-03-0808 March 2019 Shine Medical Technologies, Inc., Affidavit & Response to Request for Additional Information to Application for Order Approving Indirect Transfer of Control of Construction Permit Response to Request for Additional Information ML19024A3522019-01-22022 January 2019 Shine Medical Technologies - Meeting Slides for the January 31, 2019 Public Meeting Between Shine Medical Technologies, Inc. and the NRC ML18347A2152018-12-11011 December 2018 Shine Medical Technologies - Application for Order Approving Indirect Transfer of Control of Construction Permit and Conforming Administrative Construction Permit Amendment ML18166A1782018-06-13013 June 2018 Shine Medical Technologies, Inc., Submittal of Annual Financial Report ML17079A4762017-03-17017 March 2017 Shine Medical Technologies, Inc. - Request for Confirmation Re Proposed Demonstration Project ML16308A2212016-11-0101 November 2016 Shine Medical Technologies, Inc., Submittal of Annual Financial Report ML15222A2012015-07-23023 July 2015 Shine Medical Technologies, Inc. Application for Construction Permit Response to Request for Additional Information 6b.3-30 ML15131A4622015-05-0101 May 2015 Shine Medical Technologies, Inc. Application for Construction Permit, Response to Request for Additional Information ML15043A3952015-02-0606 February 2015 Shine Medical Technologies, Inc. - Application for Construction Permit - Response to Request for Additional Information ML14119A0432014-03-17017 March 2014 Affidavit for Shine Medical Technologies, Inc. Discussion Notes Associated with March 20, 2014 Meeting 2022-09-28
[Table view] |
Text
) ss.
COUNTY OF DANE I, Richard Vann Bynum, Chief Operating Officer of SHINE Medical Technologies, Inc. (SHINE),
do hereby affirm and state:
- 1. I am authorized to execute this affidavit on behalf of SHINE. I am authorized to review information submitted to or discussed with the Nuclear Regulatory Commission (NRC) and apply for the withholding of information from public disclosure. The purpose of this affidavit is to provide the information required by 10 CFR 2.390(b) in support of SHINE's request for proprietary treatment of certain confidential commercial information contained in the SHINE Medical Technologies, Inc. Discussion Notes Associated with March 20, 2014 Meeting with NRC. SHINE requests that the confidential information contained in the SHINE Medical Technologies, Inc. Discussion Notes Associated with March 20, 2014 Meeting with NRC be withheld from public disclosure.
- 2. I have knowledge of the criteria used by SHINE in designating information as sensitive, proprietary, or confidential.
- 3. Pursuant to the provisions of paragraph (a)(4) of 10 CFR 2.390, the following is furnished for NRC consideration in determining whether the information sought to be withheld from public disclosure should be withheld.
- a. The information sought to be withheld from public disclosure contained in the SHINE Medical Technologies, Inc. Discussion Notes Associated with March 20, 2014 Meeting with NRC is owned by SHINE, its affiliates or third parties to whom SHINE has an obligation to maintain its confidentiality. This information is and has been held in confidence by SHINE.
- b. The information sought to be protected in the SHINE Medical Technologies, Inc. Discussion Notes Associated with March 20, 2014 Meeting with NRC is not available to the public to the best of my knowledge and belief.
1
- c. The information contained in the SHINE Medical Technologies, Inc.
Discussion Notes Associated with March 20, 2014 Meeting with NRC is of the type that is customarily held in confidence by SHINE, and there is a rational basis for doing so. The information that SHINE is requesting to be withheld from public disclosure includes trade secret, commercial information or information that is subject to export controls. SHINE limits access to these elements to those individuals with a "need to know," and subject those individuals to maintaining confidentiality.
- d. The proprietary information sought to be withheld from public disclosure in the SHINE Medical Technologies, Inc. Discussion Notes Associated with March 20, 2014 Meeting with NRC includes, but is not limited to: structural configuration, primary and supporting systems of the medical isotope facility, process and system locations, and process details. This would include information regarding the types, quantities, and locations of materials stored on site as would be referenced in facility configuration drawings. Public disclosure of the information in the SHINE Medical Technologies, Inc.
Discussion Notes Associated with March 20, 2014 Meeting with NRC would create substantial harm to SHINE because it would reveal trade secrets owned by SHINE, its affiliates or third parties to whom SHINE has an obligation to maintain its confidentiality.
- e. The information contained in the SHINE Medical Technologies, Inc.
Discussion Notes Associated with March 20, 2014 Meeting with NRC is transmitted to the NRC in confidence and under the provisions of 10 CFR 2.390; it is to be received in confidence by the NRC. The information is properly marked.
I declare under the penalty of perjury that the foregoing is true and correct.
Executed on March 17, 2014.
Richard VanBynum, Ph.D.
COO - SHINE Medical Technologies, Inc.
2